There were 635 press releases posted in the last 24 hours and 150,715 in the last 365 days.

Global Neurosyphilis Market (Asymptomatic, Meningeal, Meningovascular, General Paresis, Tabes Dorsalis) Forecast to 2025

Market Research Nest

Market Research Nest

MarketResearchNest.com adds “Global Neurosyphilis Market Size, Status and Forecast 2018-2025” new reports to its research database.

PUNE, INDIA, August 30, 2018 /EINPresswire.com/ -- MarketResearchNest.com adds “Global Neurosyphilis Market Size, Status and Forecast 2018-2025” new reports to its research database. The report spread across 91 pages with tables and figures in it.

This report focuses on the global Neurosyphilis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurosyphilis development in United States, Europe and China.

Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%-40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.

Inquire before Buying at https://www.marketresearchnest.com/report/enquirybuy/419663 .

Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
In 2017, the global Neurosyphilis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi
...

Market segment by Type, the product can be split into
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
General Paresis
Tabes Dorsalis

Market segment by Application, split into
Hospital And Clinics
Medical Research Centers
Academic Institutes

Order a purchase report copy of at https://www.marketresearchnest.com/report/purchase/419663 .

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central and South America

The study objectives of this report are:
• To analyze global Neurosyphilis status, future forecast, growth opportunity, key market and key players.
• To present the Neurosyphilis development in United States, Europe and China.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Neurosyphilis are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get a Report Details at https://www.marketresearchnest.com/Global-Neurosyphilis-Market-Size-Status-and-Forecast-2018-2025.html .

About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Contact Us
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070 / +44-20-3290-4151

Mr Jeet
Market Research Nest
1-240-284-8070
email us here


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.